Released May 8, 2014, after the close
10-Q filed May 8, 2014, 38 days after period end · 0001171843-14-002257
Q1 2014 · 10-Q
Revenue$25.89M$25.89M −0.7% vs Q1 2013−7.0% vs Q4 2013
Net Income$719.00K$719.00K +649.0% vs Q1 2013N/M vs Q4 2013
EPS Diluted$0.02$0.02 — vs Q1 2013N/M vs Q4 2013
Gross Profit$11,761,000−4.1%
Operating Income$1,334,000+0.6%
Operating Cash Flow$1,072,000+86.1%
Margins · derived
Gross margin45.4%−1.6 pt vs Q1 2013
Operating margin5.2%+0.1 pt vs Q1 2013
Net margin2.8%+2.4 pt vs Q1 2013
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2014 | Q1 2013 | Q1 2012 | Q1 2011 |
|---|---|---|---|---|
| Revenue | $25.89M | $26.09M | $28.32M | $26.31M |
| Net Income | $719.00K | $96.00K | $529.00K | $1.68M |
| EPS Diluted | $0.02 | $0.00 | $0.02 | $0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Harvard Bioscience Inc · CIK 1123494 · Engraved from SEC EDGAR